Prabodhika Mallikaratchy

ORCID: 0000-0002-6437-4613
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Advanced biosensing and bioanalysis techniques
  • RNA Interference and Gene Delivery
  • DNA and Nucleic Acid Chemistry
  • Monoclonal and Polyclonal Antibodies Research
  • RNA and protein synthesis mechanisms
  • Biosensors and Analytical Detection
  • Crystallization and Solubility Studies
  • CRISPR and Genetic Engineering
  • X-ray Diffraction in Crystallography
  • Organoselenium and organotellurium chemistry
  • Protein Degradation and Inhibitors
  • Nanoplatforms for cancer theranostics
  • Advanced Biosensing Techniques and Applications
  • Chemical Thermodynamics and Molecular Structure
  • Crystal structures of chemical compounds
  • Photodynamic Therapy Research Studies
  • Chemical Synthesis and Analysis
  • CAR-T cell therapy research
  • Organometallic Compounds Synthesis and Characterization
  • Bacteriophages and microbial interactions
  • HIV Research and Treatment
  • Free Radicals and Antioxidants
  • Lymphoma Diagnosis and Treatment
  • T-cell and B-cell Immunology
  • Analytical Chemistry and Sensors

City University of New York
2015-2023

The Graduate Center, CUNY
2016-2023

Lehman College
2015-2022

Kettering University
2010-2013

University of Florida Health
2008-2010

Interface (United States)
2006-2009

New York Structural Biology Center
2009

University of Florida
2006-2008

University of Louisiana at Monroe
2003-2005

Using cell-based aptamer selection, we have developed a strategy to use the differences at molecular level between any two types of cells for identification signatures on surface targeted cells. A group aptamers been generated specific recognition leukemia The selected can bind target with an equilibrium dissociation constant ( K d ) in nanomolar-to-picomolar range. selection process is simple, fast, straightforward, and reproducible, and, most importantly, be done without prior knowledge...

10.1073/pnas.0602615103 article EN Proceedings of the National Academy of Sciences 2006-07-28

Disease biomarkers play critical roles in the management of various pathological conditions diseases. This involves diagnosing diseases, predicting disease progression and monitoring efficacy treatment modalities. While efforts to identify specific using a variety technologies has increased number or augmented information about them, effective use disease-specific is still scarce. Here, we report that high expression protein tyrosine kinase 7 (PTK7), transmembrane receptor kinase-like...

10.1021/pr700894d article EN Journal of Proteome Research 2008-03-26

A novel aptamer-based molecular probe design employing intramolecular signal transduction is demonstrated. The composed of three elements: an aptamer, a short, partially cDNA sequence, and PEG linker conjugating the aptamer with short DNA strand. We have termed this "aptamer switch probe", or ASP. ASP utilizes both fluorophore quencher which are respectively modified at two termini In absence target molecule, will hybridize keeping in close proximity, thus switching off fluorescence....

10.1021/ja804119s article EN Journal of the American Chemical Society 2008-08-05

The identification of tumor related cell membrane protein targets is important in understanding progression, the development new diagnostic tools, and potentially for identifying therapeutic targets. Here we present a novel strategy proteins that are altered their expression levels diseased using specific aptamers. Using an intact viable B-cell Burkitt's lymphoma line (Ramos cells) as target, have selected aptamers recognize with high affinity. Among showed different recognition patterns...

10.1074/mcp.m700026-mcp200 article EN cc-by Molecular & Cellular Proteomics 2007-09-18

To cut a long story short. Single-stranded DNA aptamers that can recognize cancer cells specifically were optimized and modified. The modifications gave rise to much smaller in size (see scheme) more stable fetal bovine serum. This stability makes it possible apply vivo applications, such as diagnosis therapy. Supporting information for this article is available on the WWW under http://www.wiley-vch.de/contents/jc_2268/2007/z600532_s.pdf or from author. Please note: publisher not responsible...

10.1002/cbic.200600532 article EN ChemBioChem 2007-03-20

Long-term survival still eludes most patients with leukemia and non-Hodgkin's lymphoma. No approved therapies target the hallmark of B cell, its mIgM, also known as B-cell receptor (BCR). Aptamers are small oligonucleotides that can specifically bind to a wide range molecules offer some advantages over antibodies therapeutic agents. Here, we report rational engineering aptamer TD05 into multimeric forms reactive BCR may be useful in biomedical applications. Systematic truncation coupled...

10.1093/nar/gkq996 article EN Nucleic Acids Research 2010-10-28

We report on a new strategy for identifying highly specific aptamers against predetermined epitope of target. Termed "ligand-guided selection" (LIGS), this method uniquely exploits the selection step, core SELEX (Systematic Evolution Exponential enrichment). LIGS uses naturally occurring stronger and bivalent binder, an antibody (Ab) interacting with its cognate antigen to outcompete from partially enriched pool, as strategy. demonstrate hypothesis by utilizing Ab binding membrane-bound...

10.1089/nat.2016.0611 article EN Nucleic Acid Therapeutics 2016-05-05

Aptamers are synthetic oligonucleotides that bind to their specific receptors with high specificity, offering immense potential for the development of molecular tools. Using recently introduced Ligand-Guided Selection (LIGS), a variant Systematic Evolution Ligands by Exponential Enrichment (SELEX) we previously identified anti-CD19 and anti-CD20 aptamers specificity affinity. Given expression levels, B-cell markers CD19 CD20 widely utilized in diagnosis B-cell-related malignancies autoimmune...

10.1101/2025.01.26.634939 preprint EN cc-by-nc-nd bioRxiv (Cold Spring Harbor Laboratory) 2025-01-26

We describe the synthesis of C-5 indole-tagged pyrimidine and C-8 purine nucleoside phosphoramidites their incorporation into double-stranded DNA 15 base pairs in length. Of 23 sequence modifications tested, two induced duplex to adopt a Z-like left-handed conformation under physiological salt conditions, bypassing specific sequences typically required for Z-DNA structure. The impact these varied with linker type: flexible propyl linkers exhibited distinct effects compared rigid propargyl...

10.1101/2025.01.26.634936 preprint EN bioRxiv (Cold Spring Harbor Laboratory) 2025-01-26

Protein kinase Cs are a family of serine and threonine kinases that mediate wide variety cellular signalling processes such as cell growth, differentiation, apoptosis tumor development. We have selected high-affinity DNA aptamers for PKCdelta by capillary electrophoresis based SELEX (systematic evolution ligands exponential enrichment, CE-SELEX). demonstrated fluorescently tagged PB9 aptamer can specifically recognize under in vitro conditions. The Kd the aptamer-protein binding is 122 nM....

10.1039/b604778e article EN Chemical Communications 2006-01-01

Photodynamic therapy for tumors. This paper describes the application of a molecular construct photosensitizer and an aptamer phototherapeutically targeting tumor cells. Coupled with advantages cell-SELEX in generating multiple effective aptamers diseased cell recognition, we will be able to develop highly efficient photosensitizer-based therapeutic reagents clinical applications. Supporting information this article is available on WWW under...

10.1002/cmdc.200700260 article EN ChemMedChem 2007-12-03

Abstract Nucleic acid aptamers (NAAs) are short synthetic DNA or RNA molecules that specifically fold into distinct three‐dimensional structures able to recognize a target. While NAAs show unprecedented promise in variety of applications, including sensing, therapeutics and diagnostics, one major limitation involves the lack stability towards omnipresent nucleases. Therefore, we herein report systematic truncation incorporation 2’‐O‐methyl bases aptamer, which results increased without...

10.1002/slct.201700359 article EN ChemistrySelect 2017-03-01

To discover DNA ligands against a predetermined receptor protein complex, we introduce comprehensive version of ligand-guided selection (LIGS). LIGS is, itself, variant systematic evolution by exponential enrichment (SELEX). Herein, have optimized to identify higher affinity aptamers with high specificity. In addition, demonstrate the expandability performing specific aptamer elution at 25°C, utilizing multiple monoclonal antibodies (mAbs) cultured cells and primary obtained from human...

10.1016/j.omtn.2019.05.015 article EN cc-by-nc-nd Molecular Therapy — Nucleic Acids 2019-06-04

Molecular mediation of singlet oxygen generation is demonstrated based on a newly engineered aptamer probe. Both ATP and human α-thrombin aptamers were to testify this design, both showed that the production can be triggered quantitatively mediated by presence target molecules. Moreover, photosensitizer switch (PAS) probes excellent selectivity toward their targets. These results suggest PAS serve as smart photodynamic therapy agent.

10.1002/asia.200900545 article EN Chemistry - An Asian Journal 2010-03-25

Here we are reporting, for the first time, a ligand-guided selection (LIGS) experiment using an artificially expanded genetic information system (AEGIS) to successfully identify AEGIS-DNA aptamer against T cell receptor-CD3ε expressed on Jurkat.E6 cells. Thus, have effectively combined enhanced diversity of AEGIS DNA library with LIGS develop superior screening platform discover aptamers. Libraries molecules from highly diversified building blocks will provide better ligands due more...

10.1021/acs.biochem.9b00919 article EN Biochemistry 2019-12-27

Recently, immunotherapeutic modalities with engineered cells and monoclonal antibodies have been effective in treating several malignancies. Nucleic acid aptamers can serve as alternative molecules to design agents high functional diversity. Here we report a synthetic prototype consisting of DNA that activate the T cell receptor cluster differentiation 3 (TCR-CD3) complex cultured cells. We show activation potential is similar antibody (mAb) against TCR-CD3, suggesting for developing...

10.1016/j.omtn.2020.08.016 article EN cc-by-nc-nd Molecular Therapy — Nucleic Acids 2020-08-19
Coming Soon ...